arrow
M

Matthieu Carton

Institut Curie
H指数:33
被引数:3,939

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort

与转移性乳腺癌一线抗HER2为基础治疗中表现出非凡疗效相关的临床特征:来自ESME国家队列的真实世界数据

Breast
IF7.9
2026-10-130
OA
Treatment patterns and outcomes in advanced and metastatic lung cancer in France: Results from the Epidemiological Strategy and medical Economics (ESME) database lung cancer in France

法国晚期和转移性肺癌的治疗模式与结果:来自法国流行病学策略与医学经济学(ESME)数据库的研究结果

2026-08-010
PRE
Prognostic value of PD-L1 expression and association with HRD in high-grade serous ovarian cancer: an ancillary analysis of the PAOLA-1/ENGOT-ov25 trial (GINECO)

PD-L1表达对高级别浆液性卵巢癌的预后价值及其与HRD的关联:PAOLA-1/ENGOT-ov25试验(GINECO)的附加分析

2026-01-010
OA
Regional lymph node invasion in pediatric non-rhabdomyosarcoma soft tissue sarcoma: an international cohort study from the International Soft Tissue Sarcoma Consortium

儿童非横纹肌肉瘤软组织肉瘤的区域淋巴结侵犯:国际软组织肉瘤联盟的国际队列研究

2025-08-070
PREAI
NTRK-Rearranged Mesenchymal Tumors and Related Tumors in Children, Adolescents and Young Adults: a Clinico-Pathologic and Molecular Characterization
2025-03-010
PRE
Alveolar soft part sarcomas in young patients: The French national NETSARC plus network experience
EJSO
IF2.9
2024-09-011
PRE
Trajectories and predictors of peripheral neuropathy after neoadjuvant chemotherapy in a prospective cohort of 11,014 patients with early breast cancer
2024-05-020
PRE
CANTO skin: Evaluation of skin toxicity risk factors in patients treated for breast cancer

Cant0 skin: 乳腺癌患者皮肤毒性危险因素的评估

2023-08-121
OA
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database
2023-03-084
OAAI